tiprankstipranks
Vallon Pharmaceuticals reports 2022 net loss $7M vs. $9.3M last year
PremiumThe FlyVallon Pharmaceuticals reports 2022 net loss $7M vs. $9.3M last year
2y ago
Vallon Pharmaceuticals expects to close GRI Bio deal in 1Q23
Premium
The Fly
Vallon Pharmaceuticals expects to close GRI Bio deal in 1Q23
2y ago
Vallon acquires bio-tech company GRI Bio in all-stock deal
Premium
The Fly
Vallon acquires bio-tech company GRI Bio in all-stock deal
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100